KCM
MDT icon

Kanawha Capital Management’s Medtronic MDT Stock Holding History

Kanawha Capital Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.3M Buy
130,323
+2,203
+2% +$211K 0.8% 39
2025
Q4 		$12.3M Buy
128,120
+6,961
+6% +$676K 0.85% 38
2025
Q3 		$11.5M Buy
121,159
+661
+0.5% +$60.8K 0.8% 39
2025
Q2 		$10.5M Buy
120,498
+1,348
+1% +$114K 0.78% 40
2025
Q1 		$10.7M Buy
119,150
+3,967
+3% +$355K 0.83% 39
2024
Q4 		$9.2M Sell
115,183
-4,035
-3% -$349K 0.72% 46
2024
Q3 		$10.7M Buy
119,218
+2,516
+2% +$212K 0.78% 45
2024
Q2 		$9.19M Buy
116,702
+7,337
+7% +$601K 0.72% 46
2024
Q1 		$9.53M Buy
109,365
+16,774
+18% +$1.43M 0.76% 41
2023
Q4 		$7.63M Sell
92,591
-1,047
-1% -$79.8K 0.7% 43
2023
Q3 		$7.34M Buy
93,638
+1,612
+2% +$135K 0.71% 43
2023
Q2 		$8.11M Buy
92,026
+573
+0.6% +$49.3K 0.75% 39
2023
Q1 		$7.37M Buy
91,453
+8,377
+10% +$683K 0.71% 45
2022
Q4 		$6.46M Sell
83,076
-3,076
-4% -$249K 0.63% 52
2022
Q3 		$6.96M Buy
86,152
+1,449
+2% +$130K 0.76% 46
2022
Q2 		$7.6M Buy
84,703
+2,978
+4% +$302K 0.77% 45
2022
Q1 		$9.07M Buy
81,725
+3,945
+5% +$417K 0.8% 44
2021
Q4 		$8.05M Buy
77,780
+4,135
+6% +$479K 0.68% 49
2021
Q3 		$9.23M Sell
73,645
-28
-0% -$3.62K 0.85% 41
2021
Q2 		$9.14M Buy
73,673
+337
+0.5% +$42.3K 0.84% 46
2021
Q1 		$8.66M Sell
73,336
-962
-1% -$113K 0.84% 43
2020
Q4 		$8.7M Buy
74,298
+168
+0.2% +$18.5K 0.89% 41
2020
Q3 		$7.7M Buy
74,130
+58
+0.1% +$5.83K 0.89% 40
2020
Q2 		$6.79M Buy
74,072
+1,905
+3% +$183K 0.84% 43
2020
Q1 		$6.51M Buy
72,167
+3,950
+6% +$420K 0.95% 39
2019
Q4 		$7.74M Buy
68,217
+1,842
+3% +$202K 0.9% 42
2019
Q3 		$7.21M Buy
66,375
+2,293
+4% +$239K 0.94% 40
2019
Q2 		$6.24M Buy
64,082
+6,913
+12% +$631K 0.84% 45
2019
Q1 		$5.21M Buy
57,169
+1,815
+3% +$162K 0.73% 51
2018
Q4 		$5.04M Sell
55,354
-47
-0.1% -$4.39K 0.79% 46
2018
Q3 		$5.45M Sell
55,401
-65
-0.1% -$6.01K 0.76% 47
2018
Q2 		$4.75M Buy
55,466
+739
+1% +$61.7K 0.71% 51
2018
Q1 		$4.39M Buy
54,727
+818
+2% +$67.5K 0.66% 56
2017
Q4 		$4.35M Buy
53,909
+2,825
+6% +$226K 0.64% 56
2017
Q3 		$3.97M Buy
51,084
+210
+0.4% +$17.4K 0.61% 58
2017
Q2 		$4.51M Buy
50,874
+955
+2% +$80.5K 0.7% 53
2017
Q1 		$4.02M Buy
49,919
+4,035
+9% +$315K 0.64% 56
2016
Q4 		$3.27M Sell
45,884
-5,700
-11% -$448K 0.55% 60
2016
Q3 		$4.46M Buy
51,584
+20
+0% +$1.74K 0.75% 53
2016
Q2 		$4.47M Sell
51,564
-1,185
-2% -$95.8K 0.75% 52
2016
Q1 		$3.96M Buy
52,749
+3,075
+6% +$232K 0.68% 55
2015
Q4 		$3.82M Buy
49,674
+665
+1% +$50.1K 0.69% 56
2015
Q3 		$3.28M Sell
49,009
-240
-0.5% -$17.7K 0.63% 56
2015
Q2 		$3.65M Buy
49,249
+1,203
+3% +$91.9K 0.64% 57
2015
Q1 		$3.75M Sell
48,046
-269
-0.6% -$20.4K 0.66% 55
2014
Q4 		$3.49M Buy
48,315
+875
+2% +$60.8K 0.61% 57
2014
Q3 		$2.94M Buy
47,440
+9
+0% +$572 0.54% 64
2014
Q2 		$3.02M Buy
47,431
+50
+0.1% +$3.04K 0.55% 62
2014
Q1 		$2.92M Sell
47,381
-550
-1% -$32K 0.55% 63
2013
Q4 		$2.75M Buy
47,931
+100
+0.2% +$5.67K 0.52% 65
2013
Q3 		$2.55M Hold
47,831
– – 0.53% 64
2013
Q2 		$2.46M Buy
+47,831
New +$2.36M 0.54% 63

Other funds holding MDT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Kanawha Capital Management's MDT Position: Q1 2026 in Review

Kanawha Capital Management increased its Medtronic (MDT) stake by 1.7% in Q1 2026, buying an estimated $211K and bringing the position to 130,323 shares worth $11.3M. The position accounts for 0.8% of the portfolio, ranked #39.

Kanawha Capital Management first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $12.3M in Q4 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Kanawha Capital Management held 130,323 shares of Medtronic worth $11.3M as of Q1 2026.
  • Kanawha Capital Management bought 2,203 Medtronic shares in Q1 2026, an estimated $211K.
  • Medtronic made up 0.8% of Kanawha Capital Management's portfolio in Q1 2026, its #39 holding.
  • Kanawha Capital Management first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
  • Kanawha Capital Management's Medtronic position peaked at $12.3M in Q4 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Kanawha Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.